![Wendell Wierenga](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Wendell Wierenga
Président chez
CRINETICS PHARMACEUTICALS, INC.
Fortune : 8 M $ au 30/06/2026
Profil
Wendell D.
Wierenga currently works at Crinetics Pharmaceuticals, Inc., as Chairman from 2015, Cytokinetics, Inc., as Independent Director from 2011, and Dermata Therapeutics, Inc., as Independent Director from 2016.
Dr. Wierenga also formerly worked at Syrrx, Inc., as Chief Executive Officer from 1999 to 2004, Pharmacia & Upjohn, Inc., as Executive Director-Discovery Research, The Upjohn Co., as Executive Director-Discovery Research, Onyx Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Apricus Biosciences, Inc., as Independent Director from 2014 to 2019, Aspira Women's Health, Inc., as Director, Patara Pharma LLC, as Director, SRI International, as Director, XenoPort, Inc., as Independent Director from 2011 to 2016, OCERA Therapeutics LLC, as Independent Director from 2013 to 2017, Anacor Pharmaceuticals LLC, as Independent Director from 2015 to 2016, Concert Pharmaceuticals, Inc., as Independent Director from 2014 to 2019, Warner-Lambert Co., as Vice President-Medtech Ventures from 1992 to 2000, Santarus, Inc., as Executive Vice President-Research & Development from 2011 to 2014, Parke-Davis Pharmaceutical Research, Inc., as Senior Vice President-Research from 1990 to 2000, Neurocrine Biosciences, Inc., as Executive Vice President-Research & Development from 2004 to 2006, Pfizer Inc., as Senior VP-Worldwide Pharmaceutical Sciences from 1990 to 2000, and Ambit Biosciences Corp., as Executive Vice President-Research & Development from 2007 to 2011.
Dr. Wierenga received his doctorate degree from Stanford University and undergraduate degree from Hope College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/06/2026 | 122 071 ( 0,12 % ) | 5 M $ | 30/06/2026 | |
| 27/05/2026 | 35 488 ( 0,03 % ) | 3 M $ | 30/06/2026 | |
| 30/03/2026 | 25 ( 0 % ) | 32 $ | 30/06/2026 |
Postes actifs de Wendell Wierenga
| Sociétés | Poste | Début |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Directeur/Membre du Conseil | 09/02/2011 |
| CRINETICS PHARMACEUTICALS, INC. | Président | 01/10/2015 |
| DERMATA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 20/09/2016 |
Anciens postes connus de Wendell Wierenga
| Sociétés | Poste | Fin |
|---|---|---|
Apricus Biosciences, Inc.
 Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Directeur/Membre du Conseil | 24/01/2019 |
| CONCERT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/01/2019 |
Patara Pharma LLC
 Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Provides biotechnology solutions | Directeur/Membre du Conseil | 01/11/2018 |
| OCERA THERAPEUTICS INC | Directeur/Membre du Conseil | 11/12/2017 |
| XENOPORT, INC. | Directeur/Membre du Conseil | 01/08/2016 |
Formation de Wendell Wierenga
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
23
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 23 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Warner-Lambert Co.
 Warner-Lambert Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, consumer health care and confectionery products | Health Technology |
Neurocrine Biosciences, Inc.
 Neurocrine Biosciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes treatments for neurological, neuroendocrine and neuropsychiatric disorders | Health Technology |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Apricus Biosciences, Inc.
Apricus Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Designs, develops and commercialises therapeutic products | Health Technology |
Aspira Women's Health, Inc.
 Aspira Women's Health, Inc. BiotechnologyHealth Technology Develops and manufactures diagnostic test kits | Health Technology |
Syrrx, Inc.
 Syrrx, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs | Health Technology |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Engages in acquiring, developing and commercializing pharmaceutical products for the treatment of upper & lower gastrointestinal diseases and disorders | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Patara Pharma LLC
Patara Pharma LLC Pharmaceuticals: MajorHealth Technology Provides biotechnology solutions | Health Technology |
Dermata Therapeutics, Inc.
 Dermata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which focusing on the treatment of medical and aesthetic skin conditions | Health Technology |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services Provides contract research and development services | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Hope College
 Hope College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a bio pharmaceutical company | Health Technology |
Parke-Davis Pharmaceutical Research, Inc. | |
Crinetics Pharmaceuticals, Inc.
 Crinetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics for endocrine-related diseases | Health Technology |
Choisissez Zonebourse 
